In Vivo Clinical Investigation of the Safety and Performance of Dental Implants TBR® Bone Level
NCT ID: NCT04984486
Last Updated: 2024-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
138 participants
OBSERVATIONAL
2021-09-27
2027-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
TBR® Bone Level Implants allow the patient to prevent bone resorption and maintain facial tissue and musculature support. At the functional level, the patient who benefits from implant treatment regains normal masticatory function with all the benefits on the quality of life that this can bring him.
Due to the osseointegration of the implant and the biocompatibility of the materials used, the implant treatment remains effective in the long term and makes it possible to maintain the aesthetics of the smile.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
In Vivo Clinical Investigation of the Safety and Performance of Dental Implants TBR® Tissue Level Z1
NCT04984499
Evaluation of Using Different Screwed Abutment Height
NCT06017115
Implant Survival After Insertion of Bone Level Tapered (BLT) Implant Ø 2.9 mm in the Clinical Practice Setting
NCT02699866
Randomized Clinical Trial to Evaluate the Predictability of 5.5 mm Dental Implants
NCT04929743
Analysising the Marginal Bone Loss, Torque and Implant Stability Placed in Bone and Tissue Level Dental Implants
NCT07288606
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Edentulousness causes a strong aesthetic deficit due to the lack of support of facial tissues and musculature;
* Edentulousness generates a functional deficit that can have significant repercussions on the nutritional status of the affected subject;
* Edentulousness is accompanied by bone resorption of the jawbones which is inevitable in the absence of implant treatment;
* In addition, the resulting feelings of discomfort and fragility are experienced as a real psychological handicap by the patient, partially or totally edentulous, which can then have significant repercussions on his social life.
TBR® Bone Level implants are intended for placement in the maxillary or mandibular arch in partially or completely edentulous patients for prosthetic restoration in the following cases:
* Single edentulousness,
* Intercalary edentulousness,
* Terminal edentulousness,
* Total edentulousness.
The following clinical conditions must be observed before placing a dental implant:
* Sufficient quality and volume of bone support;
* Healthy oral condition;
* no contraindications for implant setting
The expected benefits of this surgery are to improve the quality of life of patients, to recover the chewing function and the aesthetics of the smile.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dental implant
The procedure used to accomplish its intended use is as follows :
* The recipient implant site is prepared using a drilling sequence, then the implant is placed at the crestal level
* After a period of osseointegration of the implant, a transgingival healing screw is placed to allow the healing of soft tissues. After this healing phase, the final prosthesis will be loaded on the implant.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient who has completed bone growth
* Patient informed and willing to participate in the study
* Partially or totally toothless patient who will be implanted with the TBR® Bone Level implant(s) for the prospective cohort
* Patient implanted with the TBR® Bone Level implant(s) before June 2011 for the retrospective cohort
Exclusion Criteria
* Patient with bone disease of the head and neck region
* Patient refusing to participate in the study
* Patient with at least one contraindication to implantation
* Patient on osteoporosis treatment with Biphosphonates or Denosumab.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sudimplant SAS - Groupe TBR
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laurent ALLOUCHE, Dr
Role: PRINCIPAL_INVESTIGATOR
Cabinet Dentaire du Dr Laurent ALLOUCHE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cabinet du Dr ALLOUCHE
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A01913-54
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.